Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-23 · accession 0001763494-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-27 | 2026-01-23+ | TVTX | Dube Eric M | CEO, Dir | S - Sale+OE | $30.09 | -60.0K | 419.2K | -13% | -$1.81M |
| DM | 2026-01-27 | 2026-01-23+ | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $15.46 | +60.0K | 427.3K | +16% | +$927.6K |
| DM | 2026-01-27 | 2026-01-23+ | TVTX | Dube Eric M | CEO, Dir | M - OptEx | $0.00 | -60.0K | 171.9K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-23 | S | D | 8,135 | $30.01 | 419,173 | D | — | — | (F2) The weighted average sale price for the transaction reported was $30.0127, and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 2 | Common | Common Stock | 2026-01-27 | S | D | 51,865 | $30.10 | 419,173 | D | — | — | (F3) The weighted average sale price for the transaction reported was $30.097, and the range of prices were between $30.00 and $30.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 3 | Common | Common Stock | 2026-01-27 | M | A | 51,865 | $15.46 | 471,038 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-23 | M | A | 8,135 | $15.46 | 427,308 | D | — | — | |
| 5 | Derivative | Employee stock option (right to buy) | 2026-01-27 | M | D | 51,865 | $0.00 | 120,000 | D | $15.46 · — to 2030-01-31 | 51,865 Common Stock | (F4) The stock option is fully vested and exercisable. |
| 6 | Derivative | Employee stock option (right to buy) | 2026-01-23 | M | D | 8,135 | $0.00 | 171,865 | D | $15.46 · — to 2030-01-31 | 8,135 Common Stock | (F4) The stock option is fully vested and exercisable. |